OBJECTIVE: The study compares the effectiveness of two strategies for distributing azithromycin in an area with mild-to-moderate active trachoma in Nepal. METHODS: The two strategies investigated were the use of azithromycinfor 1) mass treatment of all children, or 2) targeted treatment of only those children who were found to be clinically active, as well as all members of their household. FINDINGS: Mass treatment of children was slightly more effective in terms of decreasing the prevalence of clinically active trachoma (estimated by clinical examination) and of chlamydial infection (estimated by DNA amplification tests), although neither result was statistically significant. CONCLUSION: Both strategies appeared to be effective in reducing the prevalence of clinically active trachoma and infection six months after the treatment. Antibiotic treatment reduced the prevalence of chlamydial infection more than it did the level of clinically active trachoma.
RCT Entities:
OBJECTIVE: The study compares the effectiveness of two strategies for distributing azithromycin in an area with mild-to-moderate active trachoma in Nepal. METHODS: The two strategies investigated were the use of azithromycin for 1) mass treatment of all children, or 2) targeted treatment of only those children who were found to be clinically active, as well as all members of their household. FINDINGS: Mass treatment of children was slightly more effective in terms of decreasing the prevalence of clinically active trachoma (estimated by clinical examination) and of chlamydial infection (estimated by DNA amplification tests), although neither result was statistically significant. CONCLUSION: Both strategies appeared to be effective in reducing the prevalence of clinically active trachoma and infection six months after the treatment. Antibiotic treatment reduced the prevalence of chlamydial infection more than it did the level of clinically active trachoma.
Authors: B D Gaynor; K A Holbrook; J P Whitcher; S O Holm; H C Jha; J S P Chaudhary; R C Bhatta; T Lietman Journal: Br J Ophthalmol Date: 2003-02 Impact factor: 4.638
Authors: B D Gaynor; J D Chidambaram; V Cevallos; Y Miao; K Miller; H C Jha; R C Bhatta; J S P Chaudhary; S Osaki Holm; J P Whitcher; K A Holbrook; A M Fry; T M Lietman Journal: Br J Ophthalmol Date: 2005-09 Impact factor: 4.638
Authors: Varja Sakota; Alicia M Fry; Thomas M Lietman; Richard R Facklam; Zhongya Li; Bernard Beall Journal: J Clin Microbiol Date: 2006-06 Impact factor: 5.948
Authors: S R Polack; A W Solomon; N D E Alexander; P A Massae; S Safari; J F Shao; A Foster; D C Mabey Journal: Trans R Soc Trop Med Hyg Date: 2005-03 Impact factor: 2.184
Authors: Jeremy D Keenan; Takele Lakew; Wondu Alemayehu; Muluken Melese; Travis C Porco; Elizabeth Yi; Jenafir I House; Zhaoxia Zhou; Kathryn J Ray; Nisha R Acharya; John P Whitcher; Bruce D Gaynor; Thomas M Lietman Journal: Am J Trop Med Hyg Date: 2010-03 Impact factor: 2.345
Authors: Craig W See; Wondu Alemayehu; Muluken Melese; Zhaoxia Zhou; Travis C Porco; Stephen Shiboski; Bruce D Gaynor; John Eng; Jeremy D Keenan; Thomas M Lietman Journal: Invest Ophthalmol Vis Sci Date: 2011-08-03 Impact factor: 4.799
Authors: Isobel M Blake; Matthew J Burton; Anthony W Solomon; Sheila K West; María-Gloria Basáñez; Manoj Gambhir; Robin L Bailey; David C W Mabey; Nicholas C Grassly Journal: PLoS Negl Trop Dis Date: 2010-11-02